Home » Topics » Disease categories and therapies » Immune

Immune
RSS

SB launches typhoid vaccine in first market

Aug. 20, 1998

Russian researchers describe immunomodulatory activity of thiethazole

Aug. 20, 1998

CellCept receives European approval for use in heart transplantation

Aug. 20, 1998

Kanebo reveals new immunosuppressants in the pipeline

Aug. 19, 1998

Cel-Sci reports herpes vaccines demonstrating efficacy in animals

Aug. 13, 1998

Interferon Sciences updates on status of Alferon N Injection clinical trials program

Aug. 13, 1998

DNA vaccine provides complete protection against rabies

Aug. 12, 1998

Liposomal FK-506 is effective as an immunosuppressant and antiinflammatory agent

Aug. 12, 1998

OspA vaccine prevents Lyme disease and asymptomatic infection

Aug. 11, 1998

FluMist protects against influenza infection in second year of two-year study

Aug. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...